Dr. Ashil J. Gosalia, MD

Dr. Gosalia practices at Orange Avenue Surgery Center in Orlando, Florida.

Dr. Gosalia's NPI, 1477846525, was assigned on May 24, 2011. Dr. Gosalia graduated from UMass Chan Medical School in 2011. Dr. Gosalia holds Florida license ME119259.

Dr. Gosalia's primary practice is Orange Avenue Surgery Center, at 1405 S Orange Ave Ste 120, Orlando, FL 32806. The practice phone is (321) 228-6700.

Dr. Gosalia's primary practice is Orange Avenue Surgery Center in Orlando, Florida. Dr. Gosalia is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Gosalia to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gosalia practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gosalia's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gosalia is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gosalia's licenses on file in 2 states: Florida and Rhode Island.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, irritable bowel syndrome (IBS), peptic ulcer and upper GI endoscopy among the conditions Dr. Gosalia treats.

CMS data shows 346 Medicare services from Dr. Gosalia across 10 procedure codes in 2024, for 217 Medicare patients. Medicare paid $36,668 for them.

CMS counts 217 Medicare patients who saw Dr. Gosalia in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gosalia's median patient age at 54, with 58% women.

In 2024, Dr. Gosalia wrote 496 Medicare Part D claims for 222 patients. 83% of them were for generic drugs. CMS names the drug for 395 of them, across 11 drugs with 11 or more claims each, at $117,522 in total drug cost. In 2023, CMS named 248 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Gosalia for performance year 2024, reported as part of a group. Dr. Gosalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gosalia as offering telehealth. CMS counts 72 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gosalia, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Gosalia. Dr. Gosalia's most frequent co-authors are Patricia D. Jones, MD and Paul Martin, MD.

CMS Open Payments shows 240 general payments to Dr. Gosalia from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,397.

Dr. Gosalia graduated from UMass Chan Medical School in 2011.

Dr. Gosalia is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.